Cycle structure: 1 to 3 months on therapy, followed by 2 to 3 months off, with a 5-days-on, 2-days-off weekly schedule
doi: 10.1007/s11101-023-09887-8 3
The safety profile is very favorable , no effect on insulin, IGF-1, cortisol, growth hormones
[DOI] [PubMed] [Google Scholar] 120.Romero-Gomez M, Armstrong MJ, Funuyet-Salas J, Mangla KK, Ladelund S, Sejling AS, et al
FDA-Approved Branded GLP-1 Medications: Found Health states that affiliated providers can prescribe a range of branded GLP-1 medications including Wegovy (semaglutide, FDA-approved for chronic weight management), Zepbound (tirzepatide, FDA-approved for chronic weight management), Ozempic (semaglutide, FDA-approved for type 2 diabetes and commonly prescribed off-label for weight management), Mounjaro (tirzepatide, FDA-approved for type 2 diabetes and commonly prescribed off-label for weight management), Saxenda and Victoza (liraglutide), Trulicity (dulaglutide), and Rybelsus (oral semaglutide)
Pharmacopeia (USP)-compliant, state-regulated pharmacies for plans that include medication, and only source active pharmaceutical ingredients from suppliers on the FDA green list
